JAMA Network · Dermatology

JAMA Dermatology: acceptance rate, review time, and how to prepare

In 2025, JAMA Dermatology received 3,413 manuscripts and accepted 7% overall and 7% of research manuscripts. The median first decision took 3 d without peer review and 36 d with it. Every figure below is quoted from the journal's own Year in Review editorials (2023–2025) and instructions for authors, captured 2026-09-12.

Submission requirementsJAMA Dermatology at JAMA Network ↗
Sources: 3 annual editorials · instructions for authors · Scimago 2024
3,413
Manuscripts received, 2025
1,242 research
7%
Acceptance rate, 2025
7% research
3 d
First decision without review, median
2025
36 d
First decision with review, median
2025
Last verified 2026-09-12
Source: JAMA Dermatology—The Year in Review, 2025
Acceptance rate

What is JAMA Dermatology’s acceptance rate?

The journal publishes the answer itself. Its 2025 Year in Review editorial reports 3,413 manuscripts received, 1,242 of them research manuscripts, with an overall acceptance rate of 7% and a research acceptance rate of 7%. Across 2023–2025 the research acceptance rate moved from 11% to 7% while submissions rose 24%.

YearAll manuscripts receivedResearch manuscripts receivedAcceptance, overallAcceptance, researchSource
20253,4131,2427%7%JAMA Dermatology—The Year in Review, 2025
20243,1821,1039%9%JAMA Dermatology—The Year in Review, 2024
20232,75695610%11%JAMA Dermatology—The Year in Review, 2023
Timelines

How long does JAMA Dermatology take to reach a decision?

Median days, as published by the journal. 'Without peer review' is the editorial-triage decision; 'with peer review' is the decision after external review.
YearFirst decision, no reviewFirst decision, with reviewReviewer turnaroundAcceptance to publicationReceipt to publication
20253 d36 d12 d63 d—
20244 d56 d11 d70 d163 d
20234 d47 d12 d63 d163 d
2025 Acceptance to publication improved from 70 days in 2024 to 63 days in 2025
JAMA Network peers, latest published year
JournalYearReceivedAcceptance, overallAcceptance, researchNo reviewWith review
JAMA Dermatology20253,4137%7%3 d36 d
JAMA202511,52610.4%3.9%2.1 d25 d
JAMA Internal Medicine20254,17812%4%1 d35 d
JAMA Network Open202520,2339.9%—2 d49 d
JAMA Pediatrics20253,32510%5%3 d44 d
JAMA Surgery20253,3219%5%10 d40 d
JAMA Cardiology20252,7939%5%8 d51 d
JAMA Neurology20253,2216%5%4 d35 d
JAMA Psychiatry20252,7258%5%2 d31 d
JAMA Otolaryngology–Head & Neck Surgery20251,73014%10%8 d50 d
Trend

How has it changed?

+24%
Manuscripts received, 2023 to 2025
2,756 → 3,413
11% → 7%
Research acceptance rate, 2023 to 2025
47 → 36 d
First decision with review, 2023 to 2025
Rejection

What gets papers rejected at JAMA Dermatology?

The Year in Review editorials publish volumes, rates and timelines; they do not itemize reasons for rejection. This is the general evidence, cited.
statistics #1

In a content analysis of 151 medical-education manuscripts, the top reasons for rejection were inappropriate or incomplete statistics, overinterpretation of results, and inappropriate or suboptimal instrumentation. [12][14]

44–76%

Lack of new or useful knowledge was the most common reason for rejection at AJR, accounting for 44–76% of rejections in every country. [3]

2.58 of 9

BMJ reviewers found an average of 2.58 of nine major errors deliberately inserted into a test paper; training raised this only to about 3. [18]

Before you submit

What JAMA Dermatology requires.

From the journal's instructions for authors, captured 2026-09-12. Instructions change; verify on the journal's page before submitting.
Original Investigation requirements
  • 3000 words of text (excluding abstract, tables, figures, acknowledgments, references)
  • Structured abstract, maximum 350 words
  • 50–75 references
  • No more than 5 tables and/or figures
  • Data Sharing Statement for all research articles
  • Clinical trials registered before submission; registry name, ID and URL in the abstract
  • Authorship form sent to all authors after submission
Reporting guidelines the journal names
  • CONSORT (randomized clinical trials)
  • STROBE (cohort, case-control, cross-sectional)
  • PRISMA or MOOSE (systematic reviews and meta-analyses)
  • STARD or TRIPOD (diagnostic and prognostic studies)
  • SQUIRE (quality improvement)
  • ACCORD (consensus statements)
Cover letter: Required; corresponding-author contact information and disclosure of related publications.
Protected by Anthropic’s Zero Data Retention
Your manuscript is never stored, logged, or used for training.
FAQ

Questions, answered.

Don't see yours? Email us — we read every one.

Sources

Where every number on this page comes from.

  1. Shinkai K. JAMA Dermatology—The Year in Review, 2025. Published online March 18, 2026. JAMA Dermatology—The Year in Review, 2025 (captured 2026-09-12).
  2. Shinkai K. JAMA Dermatology—The Year in Review, 2024. Published online March 19, 2025; 2025;161(5):467–469. JAMA Dermatology—The Year in Review, 2024 (captured 2026-09-12).
  3. Shinkai K. JAMA Dermatology—The Year in Review, 2023. Published online March 20, 2024. JAMA Dermatology—The Year in Review, 2023 (captured 2026-09-12).
  4. JAMA Dermatology. Instructions for Authors. jamanetwork.com/journals/jamadermatology/pages/instructions-for-authors (captured 2026-09-12).
  5. Scimago Journal Rank, 2024 edition: SJR 2.839, Q1, H-index 198, ISSN 21686068, 21686084.

Submit to JAMA Dermatology with the checklist already done.

A PeerReviewAI Peer Review audits your manuscript item by item against the reporting guideline for its design and against the author instructions you provide for JAMA Dermatology, verifies every reference against PubMed and Crossref with retraction screening, and applies the journal's formatting to your .docx as tracked changes. $49, no subscription, no verdict.

Start a review — $49Read a full sample review
For the manuscript you're submitting